69 Best Cancer Startups to Watch in 2025

The Definitive Seedtable Ranking of Cancer Startups

We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.

There are 275 start-ups with an aggregate funding of $12.7b. The average funding per company in this subset is $183.6m.

Last update to the database: Feb 18, 2025. See changelog.

See all results for this search

Track over 71,000 companies

Discover
Fast-growing Global startups

Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.

Pricing + Sign up

5

Funding Rounds

$390.0m

Money raised

PathAI is a Boston-based artificial intelligence company developing therapeutics and healthcare products.

10

Funding Rounds

$930.0m

Money raised

Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare.

1

Funding Rounds

$25.3m

Money raised

Leo Cancer Care is a company developing upright radiotherapy solutions.

4

Funding Rounds

$1.8b

Money raised

Grail is a biotechnology company headquartered in Menlo Park, California that was founded as a spinoff of Illumina Inc and initially headed by Jeffrey Huber in 2016, focused on making a medical device that can detect early stage cancer.

8

Funding Rounds

$71.3m

Money raised

Notable Labs is a company providing personalized drug combination testing service for cancer patients.

3

Funding Rounds

$313.0m

Money raised

Flatiron Health is a startup that organizes real-time oncology data to help cancer patients and doctors.

10

Funding Rounds

$410.0m

Money raised

Paige provides AI-based digital diagnostics and a vendor-neutral platform designed to drive diagnostic confidence and a more productive pathology workflow.

1

Funding Rounds

$24.1m

Money raised

Neos Therapeutics is a pharmaceutical company developing ADHD medications founded in 2008.

6

Funding Rounds

$190.5m

Money raised

Kuur Therapeutics focuses on the development of CAR-NKT cell therapies platform for applications in cancer treatment.

6

Funding Rounds

$15.8m

Money raised

Massive Bio is a New York-based company founded by Selin Kurnaz, Dr. Arturo Loaiza-Bonilla and Cagatay M. Culcuoglu, offering precision oncology services to cancer patients, providers, and pharmaceutical companies.

2

Funding Rounds

$13.8m

Money raised

A biopharmaceutical company developing therapeutics to attack cancer stem cells.

4

Funding Rounds

$140.0m

Money raised

Mission Bio is a South San Francisco based company that develops single-cell DNA analysis and precision genomics.

3

Funding Rounds

$31.2m

Money raised

Deep Lens is an Artificial Intelligence company matching patients with clinical trials.

Industries:

Key people:

2

Funding Rounds

$164.5m

Money raised

Develops novel cell and gene therapies with pharmacologic operating systems.

12

Funding Rounds

$2.8m

Money raised

HelixNano is a Cambridge, Massachusetts-based biotechnology and artificial intelligence company founded in 2013 by Hannu Rajaniemi and Nikolai Eroshenko.

8

Funding Rounds

$967.6m

Money raised

Freenome is a San Francisco-based company which uses genetic analysis for early cancer detection and risk assessment.

2

Funding Rounds

$67.5m

Money raised

A company developing immunotherapy treatments for cancers, infectious and autoimmune diseases

2

Funding Rounds

$18.1m

Money raised

A biotechnology company that develops treatments for cancer and hematologic conditions

4

Funding Rounds

$743.2m

Money raised

A bioinformatics company in San Francisco building data collection methods and databases that will enable machine learning algorithms in healthcare. It was founded in 2018.

3

Funding Rounds

$52.0m

Money raised

3T Biosciences is a biotechnology company developing immunotherapies.

7

Funding Rounds

$65.4m

Money raised

Mendel.ai is a life science company offering an artificial intelligence platform to aid clinical experts improve their clinical cancer research.

8

Funding Rounds

$160.3m

Money raised

Breathalyzer device maker for the early detection of cancer.

Key people:

1

Funding Rounds

$77.0m

Money raised

MiRXES is a Singapore-based biotechnology company specializing in microRNA-based diagnostics founded in 2014.

Location:

Key people:

5

Funding Rounds

$425.0m

Money raised

Tmunity Therapeutics is a biotechnology company developing t-cell immunotherapies for the treatment of human diseases.

3

Funding Rounds

$67.0m

Money raised

Faeth Therapeutics is a start-up that focuses on using nutrition and metabolism to fight cancer.

Location:

Key people:

2

Funding Rounds

$11.5m

Money raised

An artificial intelligence company with a focus on developing solutions for the healthcare industry. It was founded in 2017 and is located in Tel Aviv, Israel.

Industries:

Location:

Key people:

4

Funding Rounds

$96.5m

Money raised

Foundation Medicine is a Cambridge, Massachusetts-based pharmaceutical company developing diagnostic and treatment solutions for cancer care founded in 2010 by Alexis Borisy.

Key people:

1

Funding Rounds

$150.0k

Money raised

CaroGen is an immunotherapy company that develops vaccine candidates that target hepatitis B and C, as well as other viral agents.

Industries:

Key people:

5

Funding Rounds

$19.7m

Money raised

OncoSenX is a spinout company of Oisin Biotechnologies, formed to develop programmable suicide gene therapy to kill cancerous cells.

Location:

Key people:

5

Funding Rounds

$152.0m

Money raised

Synthetic biology company that created novel DNA base pairs and uses them to incorporate novel amino acids into proteins for potential therapeutics in areas of cancer and autoimmune disorders.

2

Funding Rounds

$386.0m

Money raised

Focused on transforming lives of patients with immune dysfunctions and cancer

1

Funding Rounds

Stelvio Therapeutics is a biotechnology company developing therapeutics for cancer.

14

Funding Rounds

$1.2b

Money raised

Insightec is a Tirat Carmel-based company developing and manufacturing MR-guided focused ultrasound devices for image-guided acoustic surgery.

2

Funding Rounds

$204.0m

Money raised

IGM Biosciences is an antibody Treatments.

1

Funding Rounds

Biotechnology company founded in 2015 that develops and commercializes synthetic lipid compounds and cancer immunotherapy agents. iOx Therapeutics is an OSI spinout.

Location:

Key people:

1

Funding Rounds

$2.0m

Money raised

A&G Pharmaceutical is a Columbia, Maryland-based theranostics company developing personalized cancer therapeutics through cancer-specific monoclonal antibodies.

2

Funding Rounds

$105.0m

Money raised

Eureka Therapeutics is a biotechnology company developing immunotherapies for the treatment of cancer.

3

Funding Rounds

$32.5m

Money raised

A pharmaceutical company developing tissue factor therapies for the treatment of cancer and diseases.

7

Funding Rounds

$195.5m

Money raised

Epic Sciences is a San Diego-based company founded in 2008 by Jorge Nieva, David Nelson and Peter Kuhn.

4

Funding Rounds

$270.0m

Money raised

Small Molecules

Location:

Key people:

1

Funding Rounds

$22.0m

Money raised

Biomedical Artificial Intelligence company developing products for early cancer detection in the breast.

Location:

Key people:

2

Funding Rounds

$33.8m

Money raised

A company developing immune therapies for cancer and related diseases

1

Funding Rounds

$24.0m

Money raised

Gradalis is a drug manufacturer, and developer of vaccines, tools and diagnostics for the treatment of cancer.

6

Funding Rounds

$633.0m

Money raised

Caris Life Sciences is a medical diagnostics company developing molecular profiling combined with artificial intelligence founded in 1996 by David D. Halbert.

Location:

Key people:

2

Funding Rounds

$112.0m

Money raised

Carisma Therapeutics is a biotechnology company founded in 2016 to bring the potheyr of adoptive cellular immunotherapy to solid tumor patients through a novel platform using chimeric antigen receptor macrophages (CARMA).

2

Funding Rounds

$33.9m

Money raised

Refuge Biotechnologies is a biotechnology company that uses CRISPR and cell therapy technologies for treating cancer.

Key people:

1

Funding Rounds

$32.0m

Money raised

A biotechnology company developing molecular-based diagnostic, prognostic, and predictive medical tests designed to help healthcare practitioners treat cancer.

Location:

Key people:

2

Funding Rounds

$2.6m

Money raised

Precision therapeutics company developing epigenetic therapies that target arginine methylation in cancer.

Location:

Key people:

2

Funding Rounds

$8.1m

Money raised

SEngine Precision Medicine is a precision medicine company founded by Brady Bernard, Carla Grandori, Christopher Kemp, and VK Gadi.

Location:

Key people:

1

Funding Rounds

$71.5m

Money raised

A2 Biotherapeutics, Inc. is a biotechnology research company developing T-cell therapies designed to attack solid tumors while sparing normal cells

Key people:

5

Funding Rounds

$187.0m

Money raised

Iterative Health is a Cambridge, Massachusetts-based company that provides gastroenterologists with machine learning-powered diagnostic tools to aid in the prevention of colon cancer and improve patient outcomes.

3

Funding Rounds

$200.0m

Money raised

PACT Pharma is synthesizing neo-epitope targeted T cells and producing a personalized adoptive cell therapy designed to benefit each cancer patient.

2

Funding Rounds

$128.2m

Money raised

HiberCell is a New York-based biotechnology company developing therapeutics to prevent relapse and metastasis.

Key people:

3

Funding Rounds

$13.2m

Money raised

Biosceptre is a Cambridge, Cambridgeshire-based company developing diagnostic tools and biomarkers.

1

Funding Rounds

$35.0m

Money raised

Tactiva Therapeutics is a biotechnology company developing cancer immunotherapies.

Key people:

3

Funding Rounds

$190.2m

Money raised

Cancer drugs that target specific types of poly ADP-ribose polymerase

4

Funding Rounds

$2.6m

Money raised

Cytonus Therapeutics is a biotechnology company developing adaptive cellular therapies for treating immune-oncology and inflammatory diseases.

4

Funding Rounds

$193.3m

Money raised

Amunix is an immuno-oncology company focused on developing immune-activating biotherapeutics for patients with solid tumor cancers.

4

Funding Rounds

$90.5m

Money raised

Tubulis Therapeutics is a Munich-based therapeutics company developing matched protein-drug conjugates.

Location:

Key people:

6

Funding Rounds

$107.4m

Money raised

Lunit Inc. is a deep learning AI technology-based software developer in the field of medical data analysis.

2

Funding Rounds

$40.0m

Money raised

AsclepiX Therapeutics is a Baltimore-based biotechnology company developing therapeutics for the treatment of retinal diseases and cancer.

4

Funding Rounds

$249.5m

Money raised

Boundless Bio is a pioneer in understanding and treating the most intractable cancers. They have charted a new spatial map of the cancer genome within cancer cells and are harnessing their scientific founders' discoveries about "extrachromosomal DNA," or ecDNA, to drive a revolution in cancer therapeutics.

2

Funding Rounds

$110.0m

Money raised

Octant is a biotechnology company founded by Ramsey Homsany.

Key people:

2

Funding Rounds

$2.4m

Money raised

A biotechnology company developing technology platforms to improve therapeutics discovery and manufacturing.

2

Funding Rounds

$10.0m

Money raised

Macomics is an Edinburgh-based immuno-oncology company.

Key people:

5

Funding Rounds

$56.7m

Money raised

Elypta is a Stockholm-based biotechnology company focused on preventing cancer mortality through a liquid biopsy platform for detection and monitoring of the disease.

6

Funding Rounds

$52.4m

Money raised

Endomag is an Austin, Texas-based medical diagnostics company developing detection technology for lymphatic cancers.

3

Funding Rounds

$49.2m

Money raised

Lucence Diagnostics is a California-based precision oncology company developing liquid biopsy tests for disease detection and personalized treatment.

1

Funding Rounds

$62.0m

Money raised

Pionyr Immunotherapeutics is a San Francisco-based biotechnology company and developer of cancer immunotherapies designed to target the tumor microenvironment.

Sign up to access our full database

Enter your email and get access to 71,000 + technology companies you can partner with.

Join 29000+ founders, operators, and investors.